MONTREAL, CANADA--(Marketwire - Feb. 23, 2012) - Theratechnologies Inc. (Theratechnologies) (TSX:TH)(NASDAQ:THER) today announced that John-Michel T. Huss, President and Chief Executive Officer of Theratechnologies, is scheduled to present at the 2012 RBC Capital Markets Global Healthcare Conference in New York City, on February 29, 2012 at 2:30 p.m. ET. Financial analysts, media and other interested individuals are invited to listen to the live webcast on Theratechnologies' corporate website at www.theratech.com.
About Theratechnologies
Theratechnologies (TSX:TH)(NASDAQ:THER) is a specialty pharmaceutical company that discovers and develops innovative therapeutic peptide products, with an emphasis on growth-hormone releasing factor (GRF) peptides. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on the Securities and Exchange Commission's website at www.sec.gov.
Contact Information:
NATIONAL Public Relations
514 843-2345